Home
/
Harmony Biosciences Holdings, Inc.
/
Financials
/
Quarterly
Harmony Biosciences Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Harmony Biosciences Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$239.46M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$200.49M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$184.73M
May 6, 2025
Q3
2025
Sep 30, 2024
$186.04M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$172.81M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$154.62M
May 6, 2025
Q3
2024
Sep 30, 2023
$160.27M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$134.22M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$119.13M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$117.21M
Oct 31, 2023
Q2
2023
Jun 30, 2022
$107.03M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$85.31M
May 2, 2023
Q3
2022
Sep 30, 2021
$80.73M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$73.82M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$59.67M
May 3, 2022
Q3
2021
Sep 30, 2020
$45.61M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$38.01M
Aug 10, 2021
Q1
2021
Mar 31, 2020
$19.84M
May 11, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$50.87M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$39.78M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$45.56M
May 6, 2025
Q3
2025
Sep 30, 2024
$46.09M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$11.59M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$38.33M
May 6, 2025
Q3
2024
Sep 30, 2023
$38.46M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$34.30M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$29.49M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$87.94M
Oct 31, 2023
Q2
2023
Jun 30, 2022
$23.53M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$21.49M
May 2, 2023
Q3
2022
Sep 30, 2021
($9.62M)
Nov 1, 2022
Q2
2022
Jun 30, 2021
$14.12M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$7.39M
May 3, 2022
Q3
2021
Sep 30, 2020
$1.91M
Nov 9, 2021
Q2
2021
Jun 30, 2020
($27.0K)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($38.62M)
May 11, 2021
Q3
2020
Sep 30, 2019
($31.90M)
Nov 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$65.49M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$48.18M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$56.25M
May 6, 2025
Q3
2025
Sep 30, 2024
$61.71M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$21.36M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$52.03M
May 6, 2025
Q3
2024
Sep 30, 2023
$64.51M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$46.90M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$40.42M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$11.90M
Oct 31, 2023
Q2
2023
Jun 30, 2022
$33.12M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$27.56M
May 2, 2023
Q3
2022
Sep 30, 2021
$21.05M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$23.31M
Aug 2, 2022
Q1
2022
Mar 31, 2021
$14.53M
May 3, 2022
Q3
2021
Sep 30, 2020
$10.38M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$7.31M
Aug 10, 2021
Q1
2021
Mar 31, 2020
($9.61M)
May 11, 2021
Q3
2020
Sep 30, 2019
($29.80M)
Nov 12, 2020